Surgical treatment of pancreatic neuroendocrine tumors: Report of 112 cases

Digestive Surgery

Volumn 27, Issue 3, 2010, Pages 197-204

  Gao, Chuntao ^a   Fu, Xiuqing ^b   Pan, Yi ^a   Li, Qiang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Hospital of Tianjin Port   (China)

Author keywords

Carcinoma; Neuroendocrine tumors; Pancreas; Survival

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; NEUROENDOCRINE TUMOR; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REOPERATION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77953673946     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253871     Document Type: Article

References (37)

1. Eriksson B, Oberg K: Neuroendocrine, tumors of the pancreas. Br J Surg 2000; 87: 129-131.
2. Solcia E, Capella C, Kloppel G, et al: Endocrine tumors of the gastrointestinal tract; in Solcia E, Kloppel G, Sobin LH (eds): World Health Organization International Histological Classification of Endocrine Tumors, ed 2. Lyon, LARC Press, 2000, p 61.
3. Rindi G, Klöppel G, Alhman H, et al: TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401.
4. Nicholls AG: Simple adenoma of the pancreas arising from an island of Langerhans. J Med Res 1902; 8: 385-395.
5. Howland G, Campbell WR, Maltby EJ, et al: Dysinsulinism convulsions and coma due to islet cell tumor of the pancreas, with operation and cure. JAMA 1929; 93: 674-679.
6. Grant CS: Surgical management of malignant islet cell tumors. World J Surg 1993; 17: 498-503.
7. Bassi C, Dervenis C, Butturini G, et al: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138: 8-13.
8. Kloppel G, Heitz PU: Pancreatic endocrine tumors. Pathol Res Pract 1988; 183: 155-168.
9. Lo CY, van Heerden JA, Thompson GB, et al: Islet cell carcinoma of the pancreas. World J Surg 1996; 20: 878-883.
10. Jensen RT, Norton JA: Endocrine neoplasms of the pancreas; in Yamada T (ed): Textbook of Gastroenterology, ed 2. Philadelphia, JB Lippincott, 2003, vol 2, pp 2108-2146.
11. Evans DB, Skibber JM, Lee JE, et al: Nonfunctioning islet cell carcinoma of the pancreas. Surgery 1993; 114: 1175-1182.
12. Grama D, Eriksson B, Martensson H, et al: Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg 1992; 16: 632-639.
13. Kalra MK, Maher MM, Mueller PR, et al: State-of-the-art imaging of pancreatic neoplasms. Br J Rad 2003; 76: 857-865.
14. Anderson MA, Carpenter S, Thompson NW, et al: Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 2000; 95: 2271-2277.
15. Hiramoto JS, Feldstein VA, LaBerge JM, et al: Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001; 136: 1020-1026.
16. Frucht H, Doppman JL, Norton JA, et al: Gastrinomas: comparison of MR imaging with CT, angiography, and US. Radiology 1989; 171: 713-717.
17. Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB: Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000; 214: 483-490.
18. Mantke R, Manger T, Schulz HU, et al: Multimodal treatment of neuroendocrine tumors of the pancreas and the ampulla of vater. Dig Surg 1999; 16: 145-151.
19. Norton JA, Warren RS, Kelly MG, et al: Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 2003; 134: 1057-1065.
20. Sarmiento JM, Heywood G, Rubin J, et al: Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 2003; 197: 29-37.
21. Phan GQ, Yeo CF, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL: Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998; 2: 472-482.
22. Dralle H, Krohn SL, Karges W, Boehm BO, Brauckhoff M, Gimm O: Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors. World J Surg 2004; 28: 1248-1260.
23. Sohn TA, Yeo CF, Cameron JL, et al: Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579.
24. Wynick D, Williams SJ, Bloom SR: Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors. N Engl J Med 1988; 319: 605-607.
25. Solorzano CC, Lee JE, Pisters PW, et al: Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 2001; 130: 1078-1085.
26. Chu QD, Hill HC, Douglass HO Jr, et al: Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Onc 2002; 9: 855-862.
27. Jarufe NP, Coldham C, Orug T, et al: Neuroendocrine tumors of the pancreas: predictors of survival after surgical treatment. Dig Surg 2005; 22: 157-162.
28. Fendrich V, Langer P, Celik I, et al: An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 2006; 244: 845-851.
29. Fischer L, Kleeff J, Esposito I, et al: Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumors of the pancreas. Br J Surg 2008; 95: 627-635.
30. Chung JC, Choi DW, Jo SH, et al: Malignant nonfunctioning endocrine tumors of the pancreas: predictive factors for survival after surgical treatment. World J Surg 2007; 31: 579-585.
31. Phan GQ, Yeo CJ, Hruban RH, et al: Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998; 2: 472-482.
32. Madeira I, Terris B, Voss M, et al: Prognostic factors in patients with endocrine tumors of the duodenopancreatic area. Gut 1998; 43: 422-427.
33. Arnold R, Rinke A, Klose KJ, et al: Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial. Clin Gastroenterol Hepatol 2005; 3: 761-771.
34. Jarufe NP, Coldham C, Orug T, et al: Neuroendocrine tumors of the pancreas: predictors of survival after surgical treatment. Dig Surg 2005; 22: 157-162.
35. Gullo L, Migliori M, Falconi M, et al: Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study. Am J Gastroenterol 2003; 98: 2435-2439.
36. Kang CM, Kim KS, Choi JS, et al: Experiences with nonfunctioning neuroendocrine neoplasms of the pancreas. Dig Surg 2005; 22: 453-458.
37. Panzuto F, Nasoni S, Falconi M, et al: Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 2005; 12: 1083-1092.